Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 1/20 | 0.55 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.55 |
| ▸ | TGM2 | P21980 | 10/20 | 0.52 |
| ▸ | F13A1 | P00488 | 7/20 | 0.52 |
| ▸ | TGM1 | P22735 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2376710 | 0.96 | ABL1 (0.59) | ABL1RIN1TGM2F13A1TGM1 | |
| SCHEMBL14490217 | 0.88 | TGM2 (0.53) | TGM2F13A1TGM1PKMSMN1; SMN2 | |
| SCHEMBL14490210 | 0.85 | TGM2 (0.59) | TGM2F13A1TGM1ALDH1A1PKM | |
| SCHEMBL5738205 | 0.84 | TGM2 (0.55) | TGM2F13A1TGM1ALDH1A1LMNA | |
| SCHEMBL1955697 | 0.84 | ALDH1A1 (0.62) | TGM2F13A1TGM1ALDH1A1PKM | |
| SCHEMBL5443780 | 0.84 | ABL1 (0.61) | ABL1RIN1ALDH1A1PKMLMNA | |
| SCHEMBL29596865 | 0.83 | TGM2 (0.50) | TGM2F13A1TGM1MEN1KMT2A | |
| SCHEMBL2378926 | 0.83 | TGM2 (0.56) | TGM2F13A1TGM1PKMSMN1; SMN2 | |
| SCHEMBL31165481 | 0.83 | TGM2 (0.56) | TGM2F13A1TGM1PKMSMN1; SMN2 | |
| SCHEMBL6977995 | 0.82 | TGM2 (0.58) | TGM2F13A1TGM1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070149508-A1 | Six membered heteroaromatic inhibitors targeting resistant kinase mutations | TARGEGEN, INC. (US) | 2007-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149508-A1 | Six membered heteroaromatic inhibitors targeting resistant kinase mutations | ABL1, KDR, BCR | ABL1 1/4885RIN1 2786/4885TGM2 1975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.